HIND
NASDAQ
US
Vyome Holdings, Inc. - Common Stock
$2.13
▼ $-0.02
(-0.93%)
Vol 5K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$19.4M
ROE
-300.0%
Margin
-270.6%
D/E
0.00
Beta
1.62
52W
$4–$16
Wall Street Consensus
7 analysts · Apr 20262
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.35 | $-0.21 | +$0.14 |
| Mar 2024 | $-946.56 | $-522.00 | +$424.56 |
| Dec 2023 | $-1064.88 | $-639.62 | +$425.26 |
| Sep 2023 | $-7099.20 | $-4640.00 | +$2459.20 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2025-0… |
|---|---|---|
| Revenue | $85K | $35K |
| Net Income | -$548K | -$8.6M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -96.1% | — | -96.1% | -96.1% | -96.1% | -300.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -211.8% | — | -69.7% | -69.7% | -69.7% | -270.6% |
| Gross Margin | 48.2% | — | 62.6% | 62.6% | 62.6% | 62.4% |
| D/E Ratio | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.77 | — | 2.77 | 2.77 | 2.77 | 1.94 |
Key Ratios
ROA (TTM)
-166.0%
P/S (TTM)
4.63
EPS (TTM)
$-183.14
Rev Growth 3Y
-16.2%
52W High
$16.00
52W Low
$3.57
$3.57
52-Week Range
$16.00
Financial Health
Free Cash Flow
-$374K
Net Debt
-$5.7M
Cash
$5.7M
Total Debt
$39K
As of Sep 30, 2025
How does HIND compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
HIND valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
4.6
▼
6%
below
peers
(5.0)
vs Peers
vs Industry
Fair value
P/B ratio
—
▼
0%
below
peers
(2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
HIND profitability vs Pharmaceuticals peers
ROE
-300.0%
▼
453%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
-270.6%
▼
471%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
62.4%
▼
9%
below
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-166.0%
▼
343%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
HIND financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
1.9
▼
42%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
1.6
▲
72%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
HIND fundamentals radar
HIND
Peer median
Industry
HIND profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
HIND vs peers: key metrics
Top Holders
Top 5: 1.59%Millennium Management Llc
0.80%
$96K
Focus Partners Wealth
0.26%
$31K
Vanguard Group Inc
0.22%
$26K
Geode Capital Management, L…
0.21%
$25K
Royal Bank of Canada
0.10%
$12K
As of Dec 31, 2025
Latest News
Chris Rokos: the camera-shy billionaire behind the biggest UK university donation in …
The Guardian · Apr 02
Ex-HDFC chair cites values and ethics concerns as drivers behind exit
Yahoo Finance · Apr 01
What’s Behind Applied Materials, Inc. (AMAT)’s AI Push
Yahoo Finance · Mar 23
Kotak Mahindra nears deal to buy Deutsche Bank’s India retail unit – …
Yahoo Finance · Mar 23
Gen X is facing a $400K retirement shortfall. Why they are falling …
Yahoo Finance · Mar 22